Nurix Therapeutics, Inc.
For the period ended May 19, 2025. Filed Mar 28, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 19, 2025 · Filed Mar 28, 2025
NRIX$15.30+3.1%Stored close · as of Nov 6, 2026
Contents
Compensation Program Governance
The Compensation Committee assesses the effectiveness of our executive compensation program from time to time and reviews risk mitigation and governance matters, which includes maintaining the following best practices:
| What We Do | ||
|---|---|---|
| ✔ | Pay for Performance | The majority of total executive compensation is variable and at-risk. |
| ✔ | Balance Short- and Long-Term Compensation | The allocation of incentives among annual cash incentives and long-term equity incentives does not over-emphasize short-term performance at the expense of achieving long-term goals. |
| ✔ | Combination of Balanced Performance Metrics | We use a diverse set of milestone performance metrics in our annual performance bonus plan to ensure that no single measure affects compensation disproportionately. |
| ✔ | Independent Compensation Consultant | The Compensation Committee has engaged an independent compensation consultant to provide information and advice for use in Compensation Committee decision-making. |
| ✔ | Peer Data | We develop a peer group of companies based on industry, development stage, therapeutic focus, research and development expense, market capitalization, employee headcount, and numbers of years as a public company to reference to make our compensation decisions. |
| ✔ | Clawback | We maintain a clawback policy compliant with SEC and Nasdaq rules. |
| ✔ | Double Trigger Change-in-Control Provisions | We entered into agreements with each of the NEOs that provide certain financial benefits if there is both a change in control and a termination of employment (a “double trigger”). A change in control alone would not trigger cash severance pay. |
| What We Don’t Do | ||
|---|---|---|
| ✘ | No Hedging or Pledging of Company Securities | We prohibit officers and non-employee directors from engaging in hedging and, subject to limit exceptions, pledging or short sale transactions in Company securities. |
| ✘ | No Material Perks | We do not provide material perquisites to executive officers. |
| ✘ | No Excise Tax Gross-Ups | We do not provide excise tax gross-ups. |
| ✘ | No Stock Options Below Fair Market Value | We do not grant stock options with an exercise price below fair market value. |
| ✘ | No Guaranteed Compensation | We do not have agreements with our NEOs that provide any guarantees relating to base salary increases or the amounts of any annual cash incentive awards or long-term equity awards. |
| ✘ | No Special Retirement Benefits | We do not provide defined benefit pension arrangements or post-retirement health coverage for our executive officers or employees. Our NEOs and other executives are eligible to participate in our 401(k) plan. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.